The reduced specificity of KRAS mutations for the diagnosis of PC was further underscored in another study analyzing the percentage of mutations in codons 12 and 13 of the KRAS gene among individuals with localized PC, locally advanced PC, and metastatic PC. This evidence concerns the gene KRAS and pachyonychia congenita.